Clinical Trial Update: Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate [Phase 2]

View source ↗

Summary

A Phase 2 randomized crossover trial evaluating the efficacy and safety of BDP/FF and glycopyrrolate in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BDP/FF
• Glycopyrrolate (glycopyrrolate)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED